Why This Matters Now

2026 marks a structural recalibration in health plan economics.

• Medical cost trend remains elevated.
• Utilization continues above prior modeling assumptions, with pharmacy, particularly Medicare Part D, driving significant cost acceleration. 
• Pricing resets have not consistently restored margin durability.
• Medicare Advantage operates under sustained rate, risk adjustment, and audit pressure.
• Medicaid margins remain strained.
• Exchange enrollment is tilting toward lower premium products, increasing pricing sensitivity and margin pressure. 
• SG&A discipline must coexist with automation, AI deployment, and capital preservation.

The question is no longer whether a strategy exists. It is whether the current executive configuration can deliver under sustained economic pressure. 

Margin recovery is not a pricing event.

It is an execution test.

Leadership configuration is therefore a balance sheet variable.

One misaligned executive can create disproportionate enterprise exposure.  Enterprise leaders address that risk before it becomes visible. 

An 8- to 12-week, CEO-mandated enterprise calibration of executive alignment, assumption discipline, and execution capability.

The objective is direct:

Define where leadership strength protects margin durability and where structural exposure exists before it appears in margin results, regulatory friction, or board scrutiny.

Leadership breakdown rarely appears first in financial performance.

It appears as slowed execution, capital deployed without durable return, uneven cost discipline, and stalled transformation.

By the time performance reflects it, institutional confidence has already shifted.

• A clear view of where executive configuration strengthens or weakens margin durability.
• Defined exposure across Medicare Advantage, Medicaid, Exchange, and Commercial lines.
• Assessment of leadership assumption discipline in pricing, pharmacy strategy, cost management, and capital allocation.
• Identification of execution risk across major initiatives, including AI deployment, pharmacy restructuring, and cost containment.
• Succession and retention exposure in roles critical to enterprise resilience.
• A prioritized set of CEO-level actions aligned to fiduciary responsibility and sustained performance.

The final memorandum is structured for confidential CEO use and, at your discretion, board-level discussion.

Steve McGovern has operated inside the health plan executive ecosystem since 2003. McGovern Executive Search was founded in 2011 to provide retained executive counsel exclusively to health plans and payer organizations. 

• We maintain direct dialogue with senior leaders across national and regional plans and track executive movement, succession instability, margin recalibration, and transformation strain in real time.
• We receive continuous, unvarnished insight from executives exiting health plan C-suites.  This candid leadership feedback rarely appears in formal exit interviews. 
• We see patterns before they surface in financial reporting:
  leadership capability mismatches economic pressure; consensus slows execution; high-caliber leaders disengage before performance reflects it. 

This advisory combines external market intelligence with structured internal calibration to provide a CEO-level view of enterprise leadership risk.

In a period of sustained economic pressure, leadership caliber and alignment remain the most controllable enterprise risk variables.

Engagement Structure:  Designed for decisive CEO mandate.

• Duration: 8 to 12 weeks
• Investment: $40,000 to $60,000
• CEO-mandated and confidential
• Limited engagements annually 

Initiated solely at the CEO’s discretion and conducted under strict confidentiality. 

To discuss whether this is appropriate for your enterprise, contact:

Steve McGovern
President & CEO
McGovern Executive Search
703-525-0508, Ext. 1000
steve@mcgovernexecutivesearch.com